Non-genomic action of sex steroid hormones and cardiac repolarization

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 1, 2013, Pages 8-12

  Kurokawa, Junko ^a   Furukawa, Tetsushi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Arrhythmia; Cardiac repolarization; Gender difference; Sex hormone

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; DELAYED RECTIFIER POTASSIUM CHANNEL; ESTRADIOL; ESTROGEN; IBUTILIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE; TESTOSTERONE;

ADRENERGIC SYSTEM; DISEASE PREDISPOSITION; DRUG BINDING SITE; ESTROGEN THERAPY; GENOMICS; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; LONG QT SYNDROME; MENSTRUAL CYCLE; NONHUMAN; POSTMENOPAUSE; QT PROLONGATION; REVIEW; SEX DIFFERENCE; TORSADE DES POINTES;

ANIMALS; GONADAL STEROID HORMONES; HEART; HUMANS; ION CHANNELS; LONG QT SYNDROME;

EID: 84872694200     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b212021     Document Type: Review

References (50)

1. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart, 7, 353-370 (1920).
2. Liu K, Ballew C, Jacobs DR Jr, Sidney S, Savage PJ, Dyer A, Hughes G, Blanton MM. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension, 14, 218-226 (1989).
3. D i Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Pérez GJ, Scornik FS, Antzelevitch C. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation, 106, 2004-2011 (2002).
4. Fish JM, Antzelevitch C. Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. J. Electrocardiol., 36 (Suppl), 173-179 (2003).
5. X iao L, Zhang L, Han W, Wang Z, Nattel S. Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles. Am. J. Physiol. Heart Circ. Physiol., 291, H570-H580 (2006).
6. Pham TV, Robinson RB, Danilo P Jr, Rosen MR. Effects of gonadal steroids on gender-related differences in transmural dispersion of L-type calcium current. Cardiovasc. Res., 53, 752-762 (2002).
7. Hara M, Danilo P Jr, Rosen MR. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J. Pharmacol. Exp. Ther., 285, 1068-1072 (1998).
8. Merri M, Benhorin J, Alberti M, Locati E, Moss AJ. Electrocardiographic quantitation of ventricular repolarization. Circulation, 80, 1301-1308 (1989).
9. Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam. Clin. Pharmacol., 18, 139-151 (2004).
10. Verkerk AO, Wilders R, Veldkamp MW, de Geringel W, Kirkels JH, Tan HL. Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes. Int. Heart J., 46, 1105-1118 (2005).
11. Korte T, Fuchs M, Arkudas A, Geertz S, Meyer R, Gardiwal A, Klein G, Niehaus M, Krust A, Chambon P, Drexler H, Fink K, Grohé C. Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation, 111, 2282-2290 (2005).
12. Nakagawa M, Ooie T, Ou B, Ichinose M, Takahashi N, Hara M, Yonemochi H, Saikawa T. Gender differences in autonomic modulation of ventricular repolarization in humans. J. Cardiovasc. Electrophysiol., 16, 278-284 (2005).
13. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Non-transcriptional regulation of cardiac repolarization currents by testosterone. Circulation, 112, 1701-1710 (2005).
14. Furukawa T, Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol. Ther., 115, 106-115 (2007).
15. Y ang PC, Clancy CE. Effects of sex hormones on cardiac repolarization. J. Cardiovasc. Pharmacol., 56, 123-129 (2010).
16. Y ang PC, Kurokawa J, Furukawa T, Clancy CE. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLOS Comput. Biol., 6, e1000658 (2010).
17. Lehmann MH, Hardy S, Archibald D, quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation, 94, 2535-2541 (1996).
18. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA, 270, 2590-2597 (1993).
19. Drici MD, Knollmann BC, Wang WX, Woosley RL. Cardiac actions of erythromycin: influence of female sex. JAMA, 280, 1774-1776 (1998).
20. Tamargo J. Drug-induced torsade de pointes: from molecular biology to bedside. Jpn. J. Pharmacol., 83, 1-19 (2000).
21. Hashimoto K. Arrhythmia models for drug research: classification of antiarrhythmic drugs. J. Pharmacol. Sci., 103, 333-346 (2007).
22. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog. Biophys. Mol. Biol., 94, 265-319 (2007).
23. Hreiche R, Morissette P, Turgeon J. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend. Med., 5, 124-135 (2008).
24. Fermini B, Fossa AA. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat. Rev. Drug Discov., 2, 439-447 (2003).
25. Abriel H, Schläpfer J, Keller DI, Gavillet B, Buclin T, Biollaz J, Stoller R, Kappenberger L. Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. Swiss Med. Wkly., 134, 685-694 (2004).
26. Satoh Y, Sugiyama A, Tamura K, Hashimoto K. Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome. Jpn. J. Pharmacol., 83, 327-334 (2000).
27. Takahara A, Nakamura H, Nouchi H, Tamura T, Tanaka T, Shimada H, Tamura M, Tsuruoka N, Takeda K, Tanaka H, Shigenobu K, Hashimoto K, Sugiyama A. Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heart. J. Pharmacol. Sci., 103, 181-188 (2007).
28. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, Kass RS. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science, 295, 496-499 (2002).
29. Kurokawa J. Compartmentalized regulations of ion channels in the heart. Biol. Pharm. Bull., 30, 2231-2237 (2007).
30. Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation, 97, 2237-2244 (1998).
31. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can. J. Cardiol., 8, 690-695 (1992).
32. Stramba-Badiale M, Spagnolo D, Bosi G, Schwartz PJ; Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome. Are gender differences in QTc present at birth? MISNES Investigators. Am. J. Cardiol., 75, 1277-1278 (1995).
33. Nakagawa M, Ooie T, Takahashi N, Taniguchi Y, Anan F, Yonemochi H, Saikawa T. Influence of menstrual cycle on QT interval dynamics. Pacing Clin. Electrophysiol., 29, 607-613 (2006).
34. Kadish AH, Greenland P, Limacher MC, Frishman WH, Daugherty SA, Schwartz JB. Estrogen and progestin use and the QT interval in postmenopausal women. Ann. Noninvasive Electrocardiol., 9, 366-374 (2004).
35. Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, Oren RV, Zhu ZI, Clancy CE, Isobe M, Furukawa T. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation, 116, 2913-2922 (2007).
36. Kr channels and drug-induced prolongation of cardiac repolarization. J. Physiol., 586, 2961-2973 (2008).
37. Fischmeister R, Castro L, Abi-Gerges A, Rochais F, Vandecasteele G. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 142, 136-143 (2005).
38. Asada K, Kurokawa J, Furukawa T. Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J. Biol. Chem., 284, 6014-6020 (2009).
39. Kass RS, Kurokawa J, Marx SO, Marks AR. Leucine/isoleucine zipper coordination of ion channel macromolecular signaling complexes in the heart. Roles in inherited arrhythmias. Trends Cardiovasc. Med., 13, 52-56 (2003).
40. Janse de Jonge XA, Boot CR, Thom JM, Ruell PA, Thompson MW. The influence of menstrual cycle phase on skeletal muscle contractile characteristics in humans. J. Physiol., 530, 161-166 (2001).
41. i) overloaded cardiac myocytes: a simulation study. Biophys. J., 78, 2392-2404 (2000).
42. Rodriguez I, Kilborn MJ, Liu XK, Pezzullo JC, Woosley RL. Drug-induced QT prolongation in women during the menstrual cycle. JAMA, 285, 1322-1326 (2001).
43. Hulot J-S, Démolis J-L, Rivière R, Strabach S, Christin-Maitre S, Funck-Brentano C. Influence of endogenous oestrogens on QT interval duration. Eur. Heart J., 24, 1663-1667 (2003).
44. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev., 88, 581-609 (2008).
45. D rici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation, 94, 1471-1474 (1996).
46. Fülöp L, Bányász T, Szabó G, Tóth IB, Bíró T, Lôrincz I, Balogh A, Petô K, Mikó I, Nánási PP. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol. (Oxf.), 188, 163-171 (2006).
47. Kr channels and drug-induced prolongation of cardiac repolarization. J. Physiol., 586, 2961-2973 (2008).
48. Kakusaka S, Asayama M, Kaihara A, Sasano T, Suzuki T, Kurokawa J, Furukawa T. A receptor-independent effect of estrone sulfate on the HERG channel. J. Pharmacol. Sci., 109, 152-156 (2009).
49. Sanguinetti MC, Mitcheson JS. Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol. Sci., 26, 119-124 (2005).
50. + channel structure-activity relationships and mechanisms of drug-induced QT prolongation. Annu. Rev. Pharmacol. Toxicol., 43, 441-461 (2003).